FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Product Approval Information

horizontal rule

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
Food and Drug Administration
1401 Rockville Pike
Rockville, MD 20852-1448

November 2, 2004

Submission Tracking Number (STN): BL 125020/43

Peter Patriarca, M.D.
MedImmune Vaccines, Inc.
One MedImmune Way
Gaithersburg, MD 20878

Dear Dr. Patriarca:

We have received your October 20, 2004, Supplement to your Biologics License Application (BLA) for Influenza Virus Vaccine Live, Intranasal (FluMist), to include the storage of FluMist vaccine for the current 2004-2005 influenza vaccination season in a conventional frost-free freezer without a "FreezeBox."

This acknowledgment recognizes that your submission is in the form of a "Prior Approval Supplement" as described under 21 CFR 601.12 (b)(1). This Supplement has been reviewed under STN 125020/43 and is approved effective this date.

This information will be included in your Biologics License Application file. It is recommended that a copy of this letter be available for review at the time of FDA inspections.

Sincerely yours,

--- signature ---

Jerry P. Weir, Ph.D.
Director
Division of Viral Products
Office of Vaccines Research and Review
Center for BiologicsEvaluation and Research

 

 
horizontal rule